Backtest Strategy Presets & Monte Carlo Parameters
Annualized Return (%)
18.0%
Annualized Volatility (%)
11.7%
Sample Duration (Years)
3.0 Yrs
Kurtosis / Fat-Tail Index
3.0 (Normal)
Monte Carlo Iterations
2,500 Paths
Upload Custom Daily Returns (CSV)
Permutation p-Value
0.142
p ≥ 0.05 (Luck cannot be ruled out)
Alpha Edge Verdict
FLUKE
Favorable return sequencing draw
Actual Sharpe / Median
1.54 / 0.82
Annualized Risk-Free Adjusted
Max Drawdown VaR (95%)
-18.4%
Actual MDD: -8.8% (Lucky Draw)
Luck-vs-Edge Score
34 / 100
High probability that returns rely on sequence order rather than persistent edge.
Howard Marks Insight: "Investment success requires both a good strategy and favorable sequence luck. A high backtested Sharpe over short windows frequently masks tail hazard."
Validator Proof: The Sharpe 1.53 curve exhibits severe path dependence. 14.2% of randomized permutations match or exceed this terminal equity without alpha.
[PRESET_ID]
sharpe_1_53_fluke
[SAMPLE_DAYS]
756 Daily Observations (3.0 Yrs)
[STAT_SIGNIFICANCE]
p = 0.1420 (NULL REJECTED: NO)
[95% MDD_CONFIDENCE]
[-8.8% Actual, -18.4% 95th Percentile]
[BOOTSTRAP_SHARPE_CI]
[0.42 - 1.88]
Recommendation: Do not deploy capital. Strategy requires stationary return verification across full market cycles to prove structural edge over luck.